A proposed model using glycation metrics and circulating biomarkers for the prevention of cardiovascular disease
Laboratory results of LDL, cTnI, A1c and fructosamine could be used sequentially to derive a cost-effective proxy for assessing <i>in situ</i> aging and deterioration of cardiovascular tissue. This model could theoretically predict the rate of cardiovascular aging by integrating four blood biomarkers into a dedicated algorithm guiding proactive diagnostics and treatment.
Authors
- Timothy W. Valk (ORCID: https://orcid.org/0000-0002-0345-4732)
- Carol McMorrow
Institutions
- Center for Independent Living (US)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-08-12
- DOI
- https://doi.org/10.3389/fmed.2025.1624682
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00